Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 7,034 shares at $193.73 ($1.4M) on 2024-03-11, disclosed to the SEC on 2024-03-12.
Seasonal sale ($1.4M) by Senior VP, R&D — this insider has traded RGEN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $193.73 | 3,517 | $681K | 50.0% |
| 2 | $193.73 | 3,517 | $681K | 50.0% |
| Total | $193.73 avg | 7,034 | $1.4M | 100% |
| Filing → |
| RGEN | SELL | 2022-08-12 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-09-02 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-06-14 | $2.6M | — | Filing → |